Company / EPS (Diluted)
BioCardia, Inc. EPS (Diluted) History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.29
FY2017
5-year range
-$4.29 / -$0.05
FY2013-FY2017
Trend
-1091.7%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1092% YoY in FY2017, a notable deviation from the 2-year average annual change of -856%.
Based on SEC 10-K filings.
-4.29 in FY2017.
Declined from $-0.05 to $-4.29 over the past 6 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, eps (diluted) decreased 1091.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$4.29 | -1091.7% |
| FY2016 | -$0.36 | -620.0% |
| FY2011 | -$0.05 | - |
As of FY2017 · SEC Form 10-K · Last checked Jun 21, 2026